Table 3.
NLR≥3.51 | PLR≥141.52 | N | Unfavorable outcomes, # (%) | Crude | Adjusted | ||
---|---|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | ||||
Yes | Yes | 117 | 74 (63.25) | Ref | Ref | 3.77 (2.38–5.95) | <0.001 |
Yes | No | 25 | 10 (40.00) | 0.61 (0.32, 1.18) | 0.141 | 2.32 (1.10–4.87) | 0.027 |
No | Yes | 91 | 16 (17.58) | 0.26 (0.15, 0.44) | <0.001 | 1.42 (0.75–2.70) | 0.285 |
No | No | 215 | 30 (13.95) | 0.22 (0.15, 0.34) | <0.001 | Ref | Ref |
Interaction of NLR and PLR | 1.43 (0.58, 3.50) | 0.436 | 0.71 (0.46, 1.09) | 0.114 | |||
RERI (95% CI) = 0.27 (−0.22, 0.77) | |||||||
The synergy index S = 0.73 (0.45, 1.19) |
Adjusted for age, hypertension, atrial fibrillation, NIHSS score on admission, stroke etiologic subtypes, FBG, BUN, anticoagulation agents.